With over 2,000 successful projects delivered across Europe, Odelle Technology brings a deep understanding of clinical evidence, payer expectations, and policy engagement. Our team combines expertise in health economics, reimbursement strategy, and regulatory science to accelerate your product’s pathway to adoption.

We support you across every stage of the product lifecycle—from early development to post-market expansion - helping you:

Translate trial results into compelling economic and clinical value
Secure National Guideline inclusion and HTA approval
Navigate DRG and outpatient coding systems
Engage with policy leaders, commissioners, and insurers
Build scalable market access strategies tailored to local and national systems

We are active in the UK, France, Germany, the Netherlands, Spain, Italy, Belgium, Ireland, and Scandinavia—working across oncology, infectious disease, cardiology, women’s health, orthopaedics, and digital health.

All our strategies are grounded in the latest reimbursement frameworks and HTA guidance (e.g. NICE Evidence Standards Framework, HAS economic models, G-BA benefit evaluation, and PECAN reforms).

Technologies we’ve supported are now adopted in over 300 hospitals and have secured reimbursement across 15+ healthcare systems.